Laurence Moore,Charles Zacharchuk,Sridhar K. Rabindran
申请号：
US13874147
公开号：
US20140050721A1
申请日:
2013.04.30
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A combination of temsirolimus and trastuzumab in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of a trastuzumab and a HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing trastuzumab, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.
